Gandeeva Therapeutics

• 31/01/2022
• Series A
• $40,000,000

Gandeeva Therapeutics is a rapidly growing precision biotechnology company harnessing the power of cryo-EM technology and machine learning to advance drug discovery and development at scale. Gandeeva seeks to achieve transformative societal impact on public health by revolutionizing drug discovery and by lowering the risks of late-stage clinical failures. Our unique and world-leading AI-enabled cryo-EM drug discovery platform combines deep biochemical and structural knowledge of the most important protein sites for targeting with tools to cast precision spotlights that translate this knowledge into better, faster and cheaper treatments for patients.

---

---